Quest Diagnostics (NYSE:DGX) signs an agreement to acquire LifeLabs from OMERS in a C$1.35 billion deal, including net debt.
Vous n'êtes pas connecté
TORONTO — Ontario pension fund manager OMERS has signed a deal to sell medical lab company LifeLabs to U.S.-based firm Quest Diagnostics in a deal valued at $1.35 billion including debt.
Quest Diagnostics (NYSE:DGX) signs an agreement to acquire LifeLabs from OMERS in a C$1.35 billion deal, including net debt.
LifeLabs, which provides medical laboratory testing services across Canada, has been sold to an American company. The deal, announced Wednesday, will...
LifeLabs, which provides medical laboratory testing services across Canada, has been sold to an American company. The deal, announced Wednesday, will...
Quest Diagnostics, a leading provider of diagnostic information services, announced a definitive agreement with OMERS to acquire LifeLabs, a trusted...
Quest Diagnostics (DGX) signs an agreement to acquire Allina Health's select laboratory assets. The deal is aimed at expanding Quest Diagnostics'...
HALIFAX – The private lending firm that pushed Atlantic Canada’s largest newspaper chain into insolvency in March says negotiations aimed at...
Company’s deep expertise in supporting cross-border transactions combined with parent company’s U.S. offerings can help facilitate and close...
At least 49 members of 118th Congress have violated a federal insider trading and conflicts-of-interest law, a Raw Story analysis of congressional...
Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose...
Egypt signed on Sunday four agreements in the field of green ammonia, between the Egyptian Sovereign Fund and European developers, with investments...